DIA
Drug Information Association Logo

DIA Launches New Educational Webinar Series

WASHINGTON — Feb 11, 2013

DIA today announced the launch of its Solution Provider educational webinar series. On March 11, 2013, in cooperation with ICON, DIA will kick off this program with: Oncology Clinical Trial Endpoints – Keys to Maximizing Success in your Development Programs.

ICON is the first to collaborate with DIA’s newly-created Solution Provider Webinar Program. DIA’s educational partnership with ICON will bring together leading scientists and thought leaders from the biopharma industry who will host four 90-minute webinars throughout 2013. The webinars are free to DIA members and will feature topics including oncology, strategies for late phase development, biomarkers and technology as an enabler of clinical development services.

Susan Cantrell, Director, North America at DIA said, “As the global forum for knowledge exchange, we are very excited to be launching this new program. Through the support of successful companies like ICON, we will be able to bring their invaluable solutions and experience to DIA members. Having expert presenters from both the solution-provider and industry perspectives will ensure that these webinars will meet the high-quality standards that DIA members have come to expect.”

Mr. Robert L. Howie, Jr., Chief Marketing Officer, ICON plc said, “We are delighted to work with an organization as respected as DIA to share and disseminate the industry insights we have gained from more than 20 years of helping biopharma companies bring their drugs to market faster. The webinars will discuss some of the burning challenges faced by our customers today and how ICON is bringing new ways of thinking as well as innovative solutions to help them overcome these challenges.”

 

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.

ABOUT ICON plc: ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 9,430 employees, operating from 82 locations in 40 countries.
Further information is available at www.iconplc.com